PSM Executive Director to Speak at USPTO Roundtable on Counterfeits

The United States Patent and Trademark Office Roundtable will bring together experts and stakeholders to discuss anti-counterfeiting and anti-piracy trends and strategies 


Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, will participate in the upcoming United States Patent and Trademark Office Roundtable: Future strategies in anti-counterfeiting and anti-piracy.

Panel 6: Deterring Bad Actors will feature insights from intellectual property experts and other industry and consumer stakeholders on how to prevent criminal activity in the marketplace and curb the flow of potentially dangerous products to consumers and patients.

Register for the event (held in-person and virtually) here.


Tuesday, October 3rd, 2023
10:00am-5:00pm ET
Safdar will participate in Panel 6: Deterring Bad Actors from 2:40-3:20pm.


The event is open to the public both in-person and virtually.

Clara Barton Auditorium
600 Dulany Street
Alexandria, VA 22314


Shabbir Imber Safdar has been at the Partnership for Safe Medicines for over a decade and was tapped to lead it in 2017. Shabbir is passionate about patient safety and the dangers of counterfeits, having seen firsthand the dangers of counterfeits in countries around the world where a closed, secure drug supply chain doesn't exist.

Panel 6: Deterring Bad Actors features the following speakers: Ameen Imam, Attorney Advisor, Office of Policy and International Affairs, USPTO (Moderator)

  • Tomasz R. Barczyk, Tailored IP Solutions
  • Travis Johnson, International AntiCounterfeiting Association (IACC)
  • Tim Copp, Communications Cable & Connectivity Association (CCCA)
  • Mark Manning, iTrace Technologies

Other panels throughout the day will feature perspectives from consumers, IP rights holders, representatives of online and physical marketplaces and platforms, and other private sector stakeholders. Find more information about the event here.